Loading clinical trials...
Loading clinical trials...
Exploring the Application of 3D Bioprinting Technology in Constructing Preclinical Models of Pancreatic Cancer for Drug Sensitivity Testing and Its Significance in Personalized Treatment
Conditions
Locations
2
China
China-Japan Friendship Hospital
Beijing, Beijing Municipality, China
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China
Start Date
December 1, 2022
Primary Completion Date
June 30, 2024
Completion Date
September 30, 2024
Last Updated
July 21, 2023
NCT04657068
NCT06445062
NCT04900818
NCT07432633
NCT06005493
NCT04851119
Lead Sponsor
Peking Union Medical College Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions